...
首页> 外文期刊>American Journal of Physiology >Incipient renal transplant dysfunction associates with tubular syndecan-1 expression and shedding
【24h】

Incipient renal transplant dysfunction associates with tubular syndecan-1 expression and shedding

机译:初期肾移植功能障碍与管状Syndecan-1表达和脱落

获取原文
获取原文并翻译 | 示例

摘要

Syndecan-1 is a transmembrane heparan sulfate proteoglycan involved in regenerative growth and cellular adhesion. We hypothesized that the induction of tubular syndecan-1 is a repair response to incipient renal damage in apparently stable, uncomplicated renal transplant recipients. We quantified tubular syndecan-1 in unselected renal protocol biopsies taken 1 yr after transplantation. Spearman rank correlation analysis revealed an inverse correlation between tubular syndecan-1 expression and creatinine clearance at the time of biopsy (r = -0.483, P < 0.03). In a larger panel of protocol and indication biopsies from renal transplant recipients, tubular syndecan-1 correlated with tubular proliferation marker Ki67 (r = 0.518, P < 0.0001). In a rat renal transplantation model, 2 mo after transplantation, mRNA expression of syndecan-1 and its major sheddase, A disintegrin and metallopro-teinase-17, were upregulated (both P < 0.03). Since shed syndecan-1 might end up in the circulation, in a stable cross-sectional human renal transplant population (n = 510), we measured plasma syndecan-1. By multivariate regression analysis, we showed robust independent associations of plasma syndecan-1 with renal (plasma creatinine and plasma urea) and endothelial function parameters (plasma VEGF-A, all P < 0.01). By various approaches, we were not able to localize syndecan-1 in vessel wall or endothelial cells, which makes shedding of syndecan-1 from the endothelial glycocalyx unlikely. Our data suggest that early damage in transplanted kidneys induces repair mechanisms within the graft, namely, tubular syndecan-1 expression for tubular regeneration and VEGF production for endothelial repair. Elevated plasma syndecan-1 levels in renal transplantation patients might be interpreted as repair/survival factor related to loss of tubular and endothelial function in transplanted kidneys.
机译:Syndecan-1是跨膜硫酸乙酰肝素蛋白多糖,参与再生生长和细胞粘附。我们假设管状Syndecan-1的诱导是对显然稳定,简单的肾移植受体的初始肾损伤的修复反应。我们在未选择的肾协方案活检中量化管状Syndecan-1,移植后1年。 Spearman等级相关性分析显示在活组织检查时间时管状Syndecan-1表达和肌酐清除之间的反比相关(R = -0.483,P <0.03)。在来自肾移植受体的更大面板的协议和指示活组织检查中,管状Syndecan-1与管状增殖标记Ki67相关(R = 0.518,P <0.0001)。在大鼠肾移植模型中,预移植后2Mo,同癸烷-1的mRNA表达及其主要的落液和金属氨基酶-17(P <0.03)。由于Shed Syndecan-1可能最终在循环中,在稳定的横截面人肾移植群中(n = 510),我们测量了等离子体Syndecan-1。通过多变量回归分析,我们呈现血浆二癸癸-1的强大独立关联,具有肾(血浆肌酐和血浆尿素)和内皮函数参数(血浆VEGF-A,所有P <0.01)。通过各种方法,我们无法在血管壁或内皮细胞中定位Syndecan-1,这使得从内皮甘油中的Syndecan-1的脱落不太可能。我们的数据表明,移植肾脏的早期损伤会导致移植物内的修复机制,即管状单身蛋白-1用于管状再生和VEGF生产的内皮修复。肾移植患者的升高的血浆Syndecan-1水平可能被解释为与移植肾脏的管状和内皮功能丧失相关的修复/存活因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号